Skip to main content
Clinical Trials/CTRI/2022/11/047018
CTRI/2022/11/047018
Not yet recruiting
Phase 2

Preclinical and Clinical evaluation of the effect on oral administration of VAANI KIRUTHAM along with external application of VILVAPAZHA THYLUM with the procedure of SIRASU THAARAI in the management of ALATHIDU SANNI(Attention deficit hyperactivity disorder) in paediatric age group

DR SUBBULAKSHMI S0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
DR SUBBULAKSHMI S
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR SUBBULAKSHMI S

Eligibility Criteria

Inclusion Criteria

  • 1\.HYPERACTIVITY/IN ATTENTION/ IMPULSIVITY
  • 2\.CLINICALLY DIAGNOSED AS ADHD
  • 3\.POOR CONCENTRATION
  • 4\.TALKING NONSTOP
  • 5\.BLURTING THINGS OUT
  • 6\.FREQUENT JUMPING
  • 7\.TROUBLE IN SITTING
  • 8\.INABILITY TO REACT
  • 9\.ANGRY AND ARGUE WITH OTHERS

Exclusion Criteria

  • 1\.SEIZURE DISORDERS
  • 2\.CEREBRAL PALSY
  • 3\.AUTISTIC SPECTRUM DISORDER
  • 4\.POST TRAUMATIC HEAD INJURY
  • 5\.POST ENCHEPHALITIC DISORDER

Outcomes

Primary Outcomes

Not specified

Similar Trials